By NextBestFitPay more for reliable supply
Pay a premium to manufacturers with redundant, quality-rated supply chains; long-term contracts with minimum volumes.
Pays enough to keep essential generics in supply.
Review ledgerHow this path connects
This path
Pay more for reliable supply
Concrete changes if chosen
What would actually have to change in law, agencies, payment rules, or systems.
- Pay premiums for redundant, quality-rated supply chains
- Use long-term contracts with minimum volumes
Effects
Each effect has its own page: the evidence, the case that it is or isn't a real cost, and whom it affects.
What it fixes
- Drug shortages of cheap, essential generics
Premiums and long-term contracts with minimum volumes address prices too low to sustain production and reward quality-rated, redundant supply chains.
What it creates or worsens
- Raises spending or loosens control over it
Premiums for reliable manufacturers and long-term supply contracts raise generic drug prices.
- Adds paperwork, coordination, or complexity
Paying for reliable supply requires supplier reliability ratings, which are new and complex.
Who's affected
Who gains
- People with ongoing or specialist care needs
- Drug shortages of cheap, essential generics: Essential generic shortages interrupt access to chemotherapy and emergency drugs.
- People needing emergency or trauma care
- Drug shortages of cheap, essential generics: Essential generic shortages interrupt access to chemotherapy and emergency drugs.
- Hospitals, clinics, and care organizations
- Drug shortages of cheap, essential generics: Dependence on few factories leaves hospitals exposed to essential drug shortages.
Who loses
- Taxpayers and public budgets
- Raises spending or loosens control over it: Public budgets pay the added spending.
- Health insurers, brokers, and their shareholders
- Raises spending or loosens control over it: Premiums for reliable manufacturers and long-term supply contracts raise generic drug prices.
Where it has been tried
- Civica Rx: Long-term contracts with hospitals for essential generics.
- United States: In December 2024, Civica's hospital contracting model served member systems comprising about 1,400 hospitals and over 30% of licensed U.S. hospital beds.Sources: Civica Rx (2024)